Navigation Links
New Report Just Published: World Prostate Cancer Therapeutics Market Report
Date:7/7/2009

nd reported select online sources.



    PROSTATE CANCER THERAPEUTICS
    A GLOBAL STRATEGIC BUSINESS REPORT MCP-1747


    CONTENTS


    I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

    Study Reliability and Reporting Limitations I-1
    Disclaimers I-2
    Data Interpretation & Reporting Level I-2
    Product Definitions and Scope of Study I-3
    Hormonal Therapy I-3
    Radiation Therapy I-4
    Chemotherapy I-4
    Surgical Procedures I-4
    Other Treatment Options I-4


    II. EXECUTIVE SUMMARY

    1. Industry Overview II-1
    A Prelude II-1
    New Products to Bolster Sales of Prostate Cancer Therapeutics II-1
    Key Prostate Cancer Drugs & Companies II-2
    Hormone Therapies to Dominate Global Prostate Cancer
    Therapeutics Market II-2

    Table 1: Sales of FDA Approved Prostate Cancer Hormonal
    Therapy Drugs in the US for 2007 (includes corresponding
    Graph/Chart) II-2
    Select Prostate Cancer Hormonal Therapy Drugs with Year of
    FDA Approval II-3
    Targeted Therapy - The New Frontier of Cancer Treatment II-3
    Radiotherapy - Gaining Prominence II-3
    Innovations in Drug Delivery: A Key Factor in Product
    Differentiation II-4
    New Therapies Appear Over the Horizon II-4
    New Generation Prostate Cancer Drugs and Their Area of Use II-4
    Small Cap Companies: A Target of Private Capital Financing II-5
    Drugs (that are both available and under pipeline) Developed
    by the Three Small-Cap Companies II-5
    Minimally Invasive Devices Likely to Get Good Reception in
    Emerging Markets II-5
    Awareness Drives European Prostate Cancer Therapeutics Market II-6
    Growth Drivers II-6
    Rise in Prostate Cancer Incidences & Access to Modern
    Therapeutics Foster Growth II-6

    Table 2: New Incidences of Prostate Cancer (in '000)
    Worldwide for the years 2004 through 2007 (includes
    corresponding Graph/Chart) II-6

'/>"/>
SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. QMed, Inc. Reports July Medicare SNP Enrollments
3. Phlo Affiliate Reports Expanded Coverage to Oregon Border
4. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
5. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
6. Carrington Reports Second Quarter 2007 Results
7. Avitar Reports Third Quarter Financial Results for Fiscal 2007
8. Response Genetics Reports Second Quarter 2007 Financial Results
9. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
10. Transgenomic, Inc. Reports Second Quarter 2007 Results
11. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... 28, 2015 BioStructures, LLC, a privately ... a milestone of 4,000 implantations of Signafuse® Bioactive ... in early 2014 as a bone void filler ... procedures.  This is a distinguished status among recently ... of new synthetic products have received clearance with ...
(Date:7/28/2015)... , July 28, 2015  Faced with ... that are palliative rather than symptomatic, the global ... few existing therapies capable of curing or significantly ... are starting to look towards regenerative medicine as ... a new paradigm in human health with the ...
(Date:7/27/2015)... ... , ... Production of high tenacity filament yarn of viscose rayon (excluding sewing ... instance, it surpassed the EUR 106 million mark (in value terms) in 2013, while ... major producer, while Italy is a key consumer. , The high tenacity filament ...
(Date:7/27/2015)... , July 27, 2015 According ... by Type (Home-brew Media, Pre-formulated Media), by Application (Biobanking, Regenerative ... , Europe , Asia-Pacific ... 2019", The global biopreservation media market was valued at $247.7 ... $571.5 million by 2019, at a CAGR of 18.2% between ...
Breaking Biology Technology:Revolutionary Bone Graft Exceeds Expectations 2Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 2Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 3Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 4Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 5High Tenacity Filament Yarn of Viscose Rayon Consumption to Grow Swiftly in the EU, Forecasts BAC Reports in New Study Available at MarketPublishers.com 2Global Biopreservation Media Market to be Worth $571.5 Million by 2019 2Global Biopreservation Media Market to be Worth $571.5 Million by 2019 3
... , , , ... Knighted Computer Systems, Inc. (Knighted), a leading provider of Supply Chain ... member of InfoLogix, Inc. (Nasdaq: IFLG ) has joined ... , "Mr. Wilensky joins Knighted bringing his extensive ...
... DUBLIN, August 5 , - 2009 Guidance Framework Reaffirmed , Shire plc (LSE: ... Q2 2009 Financial Highlights, ... Q2 2009(1), Product sales ... $558 million -21%, Product sales (excluding ...
... , SAN DIEGO, Aug. 5 Optimer Pharmaceuticals, Inc. (Nasdaq: ... ended June 30, 2009. Optimer reported a net loss for the ... was in line with the Company,s expectations. This compares to a net ... per share. The increase in net loss was primarily due to ...
Cached Biology Technology:Knighted Adds Industry Pioneer and Entrepreneur to Senior Management Team 2Knighted Adds Industry Pioneer and Entrepreneur to Senior Management Team 3Shire plc: Core Portfolio of Products Delivers 20% Sales Growth 2Shire plc: Core Portfolio of Products Delivers 20% Sales Growth 3Shire plc: Core Portfolio of Products Delivers 20% Sales Growth 4Shire plc: Core Portfolio of Products Delivers 20% Sales Growth 5Shire plc: Core Portfolio of Products Delivers 20% Sales Growth 6Shire plc: Core Portfolio of Products Delivers 20% Sales Growth 7Shire plc: Core Portfolio of Products Delivers 20% Sales Growth 8Shire plc: Core Portfolio of Products Delivers 20% Sales Growth 9Shire plc: Core Portfolio of Products Delivers 20% Sales Growth 10Shire plc: Core Portfolio of Products Delivers 20% Sales Growth 11Shire plc: Core Portfolio of Products Delivers 20% Sales Growth 12Shire plc: Core Portfolio of Products Delivers 20% Sales Growth 13Shire plc: Core Portfolio of Products Delivers 20% Sales Growth 14Shire plc: Core Portfolio of Products Delivers 20% Sales Growth 15Shire plc: Core Portfolio of Products Delivers 20% Sales Growth 16Shire plc: Core Portfolio of Products Delivers 20% Sales Growth 17Shire plc: Core Portfolio of Products Delivers 20% Sales Growth 18Shire plc: Core Portfolio of Products Delivers 20% Sales Growth 19Shire plc: Core Portfolio of Products Delivers 20% Sales Growth 20Shire plc: Core Portfolio of Products Delivers 20% Sales Growth 21Shire plc: Core Portfolio of Products Delivers 20% Sales Growth 22Shire plc: Core Portfolio of Products Delivers 20% Sales Growth 23Shire plc: Core Portfolio of Products Delivers 20% Sales Growth 24Shire plc: Core Portfolio of Products Delivers 20% Sales Growth 25Shire plc: Core Portfolio of Products Delivers 20% Sales Growth 26Shire plc: Core Portfolio of Products Delivers 20% Sales Growth 27Shire plc: Core Portfolio of Products Delivers 20% Sales Growth 28Shire plc: Core Portfolio of Products Delivers 20% Sales Growth 29Shire plc: Core Portfolio of Products Delivers 20% Sales Growth 30Shire plc: Core Portfolio of Products Delivers 20% Sales Growth 31Shire plc: Core Portfolio of Products Delivers 20% Sales Growth 32Shire plc: Core Portfolio of Products Delivers 20% Sales Growth 33Optimer Pharmaceuticals Reports Second Quarter 2009 Financial Results 2
(Date:7/9/2015)... July 07, 2015 ... addition of the "Biometrics for Banking; Market ... report to their offering. The ... to this growth and the forecast is that ... revenue for companies involved in delivering biometric systems ...
(Date:7/8/2015)... 8, 2015  Trovagene, Inc. (NASDAQ: TROV ... announced the launch of a study that aims ... Monitoring℠ (PCM) technology for predicting response to treatment ... combination of the novel immunotherapy agents Yervoy® (ipilumumab), ... inhibitor. The 50-patient study will be led by ...
(Date:7/2/2015)... , June 25, 2015 ... announced the addition of the "Natural Language ... Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) ... their offering. The key vendors occupying ... HP, IBM Corporation, Microsoft Corporation, NetBase Solutions, SAS ...
Breaking Biology News(10 mins):Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2
... Genomatix Software GmbH, an in silico systems biology company ... in Dublin, Ireland and Boston, U.S.A. identified novel cancer ... promoted by Genomatix. Experimental verification by siRNA knock-down and ... delighted that an ever increasing number of scientists proof ...
... when it is carried out by the biopolymers which ... devise new ways for molecules to self assemble into ... with the Macromolecules and Interfaces Institute (MII www.mii.vt.edu ... the online issue for the Journal of the American ...
... the Centre of Environment and Hydrology (CEH) have investigated ... caterpillars live as parasites inside colonies of Myrmica ants, ... One of the peculiar features of this species' ecology ... development within one year. The rest are inactive in ...
Cached Biology News:Some caterpillers just don't want to grow up 2
... system, 100-120 V, is used for biolistic ... handheld device employs an adjustable helium pulse ... gold microcarriers from the inner wall of ... cells. This system has a 2 square-centimeter ...
... Clean and Accurate Results Laser Capture ... the sensitivity and accuracy of molecular assays ... types and multi-cellular structures isolated from whole ... to microdissection-developed in 1996 at the National ...
...
Mouse monoclonal antibody raised against a partial recombinant DHX8. NCBI Entrez Gene ID = DHX8...
Biology Products: